US EditionFDA’s new expert panels are rife with financial conflicts and fringe views
FDA convened expert panels including physicians with financial conflicts and fringe views to discuss drug safety, raising concerns about the balance and transparency of these sessions.
- The FDA's new 'expert panels' feature doctors with financial conflicts and fringe views on topics like antidepressant safety.
- A July panel on antidepressants concluded they should carry the strongest warning about risks to mothers and babies, contradicting scientific consensus.
- Former FDA officials say the informal panels skirt transparency rules and could be legally challenged if used for regulatory decisions.
Insights by Ground AI
Does this summary seem wrong?
36 Articles
36 Articles
Associated Press News+35 Reposted by 35 other sources
FDA's new expert panels are rife with financial conflicts and fringe views
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules and promoting fringe views about antidepressants and other products.
·United States
Read Full ArticleCoverage Details
Total News Sources36
Leaning Left4Leaning Right3Center26Last UpdatedBias Distribution79% Center
Bias Distribution
- 79% of the sources are Center
79% Center
12%
C 79%
Factuality
To view factuality data please Upgrade to Premium
